This could be the case when GC-specific codeletion of Crebbp/Kmt2d is introduced in the FL-prone Bcl2-transgenic background, recapitulating the genetic makeup of FL/tFL and DLBCL. This evidence concerns the gene CREBBP and diffuse large B-cell lymphoma.